<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">patmedfar</journal-id><journal-title-group><journal-title xml:lang="ru">Пациентоориентированная медицина и фармация</journal-title><trans-title-group xml:lang="en"><trans-title>Patient-Oriented Medicine and Pharmacy</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-1924</issn><publisher><publisher-name>LLC Izdatelstvo OKI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2949-1924-0111</article-id><article-id custom-type="edn" pub-id-type="custom">JBWPRC</article-id><article-id custom-type="elpub" pub-id-type="custom">patmedfar-197</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВНУТРЕННИЕ БОЛЕЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INTERNAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Значение показателей индуцированного окисления крови в патогенезе развития осложнений при реваскуляризации миокарда</article-title><trans-title-group xml:lang="en"><trans-title>Role of induced blood oxidation parameters in the pathogenesis of complications during myocardial revascularization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5362-8702</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шерешнева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shereshneva</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шерешнева Марина Владимировна - ассистент кафедры терапии им. профессора Е. Н. Дормидонтова</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Marina V. Shereshneva - Assistant, Department of Therapy named after professor E. N. Dormidontov</p><p>Yaroslavl</p></bio><email xlink:type="simple">m.shereshneva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0032-0341</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлов</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlov</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хохлов Александр Леонидович - д. м. н., профессор, академик РАН, зав. кафедрой фармакологии и клинической фармакологии, ректор</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Alexander L. Khokhlov - Dr. Sci. (Med.), professor, Academician of the Russian Academy of Sciences, Head of the Department of Pharmacology and Clinical Pharmacology, Rector</p><p>Yaroslavl</p></bio><email xlink:type="simple">rector@ysmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ярославский государственный медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2025</year></pub-date><volume>3</volume><issue>4</issue><fpage>5</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шерешнева М.В., Хохлов А.Л., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Шерешнева М.В., Хохлов А.Л.</copyright-holder><copyright-holder xml:lang="en">Shereshneva V.V., Khokhlov A.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pomph.ru/jour/article/view/197">https://www.pomph.ru/jour/article/view/197</self-uri><abstract><p>Актуальность. Хирургическое лечение ишемической болезни сердца (ИБС), несмотря на доказанное положительное влияние на прогноз и качество жизни пациентов, сопровождается развитием феномена-ишемии реперфузии, в основе которого лежит окислительный стресс, опосредующий развитие наиболее распространённых послеоперационных осложнений.Материалы и методы. Группа наблюдения представлена 89 больными стабильной ИБС, в т. ч. 64 пациента, которым было выполнено шунтирование коронарных артерий, группу контроля составили 24 здоровых добровольца. Оценка показателей индуцированного окисления крови проводилась на биологическом кислородном мониторе YSI 5300 (Yellow Springs Instrument Company, YSI Inc., США).Результаты. У пациентов со стабильной ИБС по сравнению с группой контроля наблюдались более высокие показатели Vox (2,07&gt;1,9; p=0,049), Vinit (3,29&gt;2,11; р=0,0001), Vmax (3,5&gt;2,54; p=0,001), коэффициента окислительной активности КА (40,0&gt;5,89, p=0,0001), более короткий период инициации T (0,97&lt;1,91; p=0,001). В сравнительном аспекте статистически значимых различий показателей индуцированного окисления крови в зависимости от вида кардиохирургического вмешательства не наблюдалось как через 10 суток (В2), так и через 6 месяцев после операции (В3). В группе больных, ранее перенёсших инфаркт миокарда, значения Vox были статистически значимо выше в случае наступления летального исхода (2,3 (2,3; 2,5) и 1,9 (1,7; 2,3) соответственно, р=0,04). Результаты логистического регрессионного анализа продемонстрировали статистически значимое влияние значений Vox на развитие нарушений ритма сердца (p=0,0001) и когнитивной дисфункции (р=0,004) в послеоперационном периоде.Выводы. Пациенты с ИБС демонстрируют более высокие значения показателей индуцированного окисления крови. Выбор методики реваскуляризации (в условиях искусственного кровообращения или на работающем сердце) не оказывает влияния на эти показатели, однако их мониторинг в рамках периоперационного ведения больных, как представляется, может использоваться с целью прогнозирования развития таких осложнений, как нарушения ритма и послеоперационная когнитивная дисфункция.</p></abstract><trans-abstract xml:lang="en"><p>Background. Despite its proven positive impact on prognosis and quality of life, coronary artery disease (CAD) surgical treatment is accompanied by the development of ischemia-reperfusion injury, a phenomenon underpinned by oxidative stress that mediates the development of the most common postoperative complications.Materials and methods. The study group consisted of 89 patients with CAD, including 64 patients who underwent coronary artery bypass grafting. The control group consisted of 24 healthy volunteers. Blood oxidation parameters were assessed using a YSI 5300 biological oxygen monitor (Yellow Springs Instrument Co., Inc., USA).Results. In patients with CAD, compared with the control group, higher values of Vox (2.07 &gt; 1.9; p = 0.049), Vinit (3.29 &gt; 2.11; p = 0.0001), Vmax (3.5 &gt; 2.54; p = 0.001), coefficient of oxidative activity (KA) (40.0 &gt; 5.89, p = 0.0001), and a shorter initiation period (T) (0.97 &lt; 1.91; p = 0.001) were observed. In the comparative aspect, statistically significant differences in the indices of induced blood oxidation depending on the type of cardiac surgery were not observed either 10 days (B2) or 6 months after the operation (B3). In the group of patients who had previously suffered a myocardial infarction, the Vox values were statistically significantly higher in the event of a fatal outcome (2.3 (2.3; 2.5) and 1.9 (1.7; 2.3), respectively (p = 0.04). The results of the logistic regression analysis demonstrated a statistically significant effect of the Vox value on the development of cardiac arrhythmias (p = 0.0001) and cognitive dysfunction (p = 0.004) in the postoperative period.Conclusions. Patients with CAD had higher blood oxidation parameters. The choice of revascularization technique (cardiopulmonary bypass or off-pump surgery) did not affect these parameters. However, monitoring these parameters during perioperative patient care appears to be useful for predicting the development of complications such as cardiac arrhythmias and postoperative cognitive dysfunction.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>окислительный стресс</kwd><kwd>коронарное шунтирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary artery disease</kwd><kwd>oxidative stress</kwd><kwd>coronary artery bypass grafting</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chong B, Jayabaskaran J, Jauhari SM, et al. The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050. J Am Coll Cardiol. 2025 Jul 22;86(3):165-177. doi: 10.1016/j.jacc.2025.04.061.</mixed-citation><mixed-citation xml:lang="en">Chong B, Jayabaskaran J, Jauhari SM, et al. The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050. J Am Coll Cardiol. 2025 Jul 22;86(3):165-177. doi: 10.1016/j.jacc.2025.04.061.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Самородская И.В., Чернявская Т.К Т.К., Какорина Е.П., Семенов В.Ю. Ишемические болезни сердца: анализ медицинских свидетельств о смерти. Российский кардиологический журнал. 2022;27(1):4637. https://doi.org/10.15829/1560-4071-2022-4637</mixed-citation><mixed-citation xml:lang="en">Samorodskaya I.V., Chernyavskaya T.K., Kakorina E.P., Semyonov V.Yu. Ischemic heart disease: medical certificate of cause of death analysis. Russian Journal of Cardiology. 2022;27(1):4637. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Poznyak AV, Grechko AV, Orekhova VA, et al. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology (Basel). 2020 Mar 21;9(3):60. doi: 10.3390/biology9030060.</mixed-citation><mixed-citation xml:lang="en">Poznyak AV, Grechko AV, Orekhova VA, et al. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology (Basel). 2020 Mar 21;9(3):60. doi: 10.3390/biology9030060.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Papadakis E, Kanakis M, Kataki A, Spandidos DA. The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (Review). Mol Med Rep. 2018 Feb;17(2):2089-2099. doi: 10.3892/mmr.2017.8174.</mixed-citation><mixed-citation xml:lang="en">Papadakis E, Kanakis M, Kataki A, Spandidos DA. The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (Review). Mol Med Rep. 2018 Feb;17(2):2089-2099. doi: 10.3892/mmr.2017.8174.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vukicevic P, Klisic A, Neskovic V, et al. Oxidative Stress in Patients before and after On-Pump and Off-Pump Coronary Artery Bypass Grafting: Relationship with Syntax Score. Oxid Med Cell Longev. 2021 Jul 30;2021:3315951. doi: 10.1155/2021/3315951.</mixed-citation><mixed-citation xml:lang="en">Vukicevic P, Klisic A, Neskovic V, et al. Oxidative Stress in Patients before and after On-Pump and Off-Pump Coronary Artery Bypass Grafting: Relationship with Syntax Score. Oxid Med Cell Longev. 2021 Jul 30;2021:3315951. doi: 10.1155/2021/3315951.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ghezzi P. Environmental risk factors and their footprints in vivo - A proposal for the classification of oxidative stress biomarkers. Redox Biol. 2020 Jul;34:101442. doi: 10.1016/j.redox.2020.101442.</mixed-citation><mixed-citation xml:lang="en">Ghezzi P. Environmental risk factors and their footprints in vivo - A proposal for the classification of oxidative stress biomarkers. Redox Biol. 2020 Jul;34:101442. doi: 10.1016/j.redox.2020.101442.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Varadhan S, Venkatachalam R, Perumal SM, Ayyamkulamkara SS. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients. Arch Razi Inst. 2022 Apr 30;77(2):853-859. doi: 10.22092/ARI.2022.357069.1965.</mixed-citation><mixed-citation xml:lang="en">Varadhan S, Venkatachalam R, Perumal SM, Ayyamkulamkara SS. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients. Arch Razi Inst. 2022 Apr 30;77(2):853-859. doi: 10.22092/ARI.2022.357069.1965.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen D, Liang M, Jin C, et al. Expression of inflammatory factors and oxidative stress markers in serum of patients with coronary heart disease and correlation with coronary artery calcium score. Exp Ther Med. 2020 Sep;20(3):2127-2133. doi: 10.3892/etm.2020.8958.</mixed-citation><mixed-citation xml:lang="en">Chen D, Liang M, Jin C, et al. Expression of inflammatory factors and oxidative stress markers in serum of patients with coronary heart disease and correlation with coronary artery calcium score. Exp Ther Med. 2020 Sep;20(3):2127-2133. doi: 10.3892/etm.2020.8958.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Alam SR, Stirrat C, Spath N, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017 Dec 16;12(1):115. doi: 10.1186/s13019-017-0681-6.</mixed-citation><mixed-citation xml:lang="en">Alam SR, Stirrat C, Spath N, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017 Dec 16;12(1):115. doi: 10.1186/s13019-017-0681-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto M, Nishimori H, Fukutomi T, et al. Dynamics of Oxidative Stress Evoked by Myocardial Ischemia Reperfusion After Off-Pump Coronary Artery Bypass Grafting Elucidated by Bilirubin Oxidation. Circ J. 2017 Oct 25;81(11):1678-1685. doi: 10.1253/circj.CJ-16-1116.</mixed-citation><mixed-citation xml:lang="en">Yamamoto M, Nishimori H, Fukutomi T, et al. Dynamics of Oxidative Stress Evoked by Myocardial Ischemia Reperfusion After Off-Pump Coronary Artery Bypass Grafting Elucidated by Bilirubin Oxidation. Circ J. 2017 Oct 25;81(11):1678-1685. doi: 10.1253/circj.CJ-16-1116.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou M, Yu Y, Luo X, et al. Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective. Cardiology. 2021;146(6):781-792. doi: 10.1159/000518879.</mixed-citation><mixed-citation xml:lang="en">Zhou M, Yu Y, Luo X, et al. Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective. Cardiology. 2021;146(6):781-792. doi: 10.1159/000518879.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci. 2018 Mar;63(1):30-35. doi: 10.1016/j.advms.2017.06.005.</mixed-citation><mixed-citation xml:lang="en">Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci. 2018 Mar;63(1):30-35. doi: 10.1016/j.advms.2017.06.005.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zakkar M, Ascione R, James AF, et al. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015 Oct;154:13-20. doi: 10.1016/j.pharmthera.2015.06.009.</mixed-citation><mixed-citation xml:lang="en">Zakkar M, Ascione R, James AF, et al. Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. Pharmacol Ther. 2015 Oct;154:13-20. doi: 10.1016/j.pharmthera.2015.06.009.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mustroph J, Neef S, Maier LS. CaMKII as a target for arrhythmia suppression. Pharmacol Ther. 2017 Aug;176:22-31. doi: 10.1016/j.pharmthera.2016.10.006.</mixed-citation><mixed-citation xml:lang="en">Mustroph J, Neef S, Maier LS. CaMKII as a target for arrhythmia suppression. Pharmacol Ther. 2017 Aug;176:22-31. doi: 10.1016/j.pharmthera.2016.10.006.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ren X, Wang X, Yuan M, et al. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation. Curr Pharm Des. 2018;24(26):3062-3071. doi: 10.2 174/1381612824666180903144042.</mixed-citation><mixed-citation xml:lang="en">Ren X, Wang X, Yuan M, et al. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation. Curr Pharm Des. 2018;24(26):3062-3071. doi: 10.2 174/1381612824666180903144042.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Полушин Ю.С., Полушин А.Ю., Юкина Г.Ю., Кожемякина М.В. Послеоперационная когнитивная дисфункция – что мы знаем и куда двигаться далее. Вестник анестезиологии и реаниматологии. 2019;16(1):19-28. https://doi.org/10.21292/2078-5658-2019-16-1-19-28</mixed-citation><mixed-citation xml:lang="en">Polushin Yu.S., Polushin A. Yu., Yukina G.Yu., Kozhemyakina M.V. Postoperative cognitive dysfunction – what we know and where we go. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2019;16(1):19-28. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018 May;15:490-503. doi: 10.1016/j.redox. 2018.01.008.</mixed-citation><mixed-citation xml:lang="en">Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018 May;15:490-503. doi: 10.1016/j.redox. 2018.01.008.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
